Richmond’s Sinus and Allergy Specialists

LATERA® Absorbable Nasal Implant

The LATERA Absorbable Nasal Implant is used to support upper and lower lateral cartilage in your nose. It is placed inside the lateral (side) wall of the nose to support the cartilage, reducing nasal airway obstruction symptoms and helping patients breathe better.6,7 The implant material, which absorbs over a period of approximately 18 months, has an extensive history of use in a variety of medical applications.

Are you experiencing the following symptoms?

  • Nasal congestion or stuffiness
  • Nasal blockage or obstruction
  • Trouble breathing through your nose
  • Trouble sleeping
  • Unable to get enough air through your nose during exercise or exertion

More than 20 million Americans1 are estimated to suffer from nasal airway obstruction, which limits airflow through the nose with significant quality-of-life consequences.2

Video

Dr. Michael Armstrong at Richmond ENT performs a 10 minute correction of chronic nasal blockage on under light sedation. She has immediate recovery and dramatic relief. Prior to surgery, she slept with her hand pulling the cheek outward, an adaptation known as the Cottle maneuver. The only alternative for her was to wear Breathe Right strips. The Latera implants strengthen the sidewalls of her the nose and allow her to breathe freely night and day. This simple procedure is much less invasive than a traditional septoplasty or rhinoplasty.

View an animation of the LATERA Absorbable Nasal Implant:

What Patients Have Experienced With LATERA

LATERA may help you breathe better with little risk of changes to appearance. 9 out of 10 patients who received the LATERA implant were satisfied overall including post-procedure breathing and appearance.8

Clinical studies show that LATERA patients demonstrate:6

  • Reduced nasal congestion or stuffiness
  • Less trouble breathing through the nose
  • Improved ability to get enough air through the nose during exercise or exertion
  • Reduced nasal blockage or obstruction
  • Less trouble sleeping

Risks included temporary symptoms such as:

  • Mild bruising and inflammation
  • Awareness of the implant
  • Mild pain or irritation

Other risks related to the LATERA implant included: discomfort, infection, reaction to material, and device retrieval.

What Patients Are Saying About LATERA*

Nancy’s Story

“Nasal sprays gave me minor relief, but I felt like I was putting a band-aid on the situation… I contacted an ENT specialist and they discovered I have a deviated septum. Another thing they discovered is that I had internal valve collapse… They inserted LATERA and that prevented the valve collapse in my nose. I immediately noticed a difference… I could breathe. I noticed immediately, the increased airflow.”

Candace’s Story

“The most appealing thing about LATERA to me was my appearance wouldn’t really change…The very next day I went out and saw people that I know, and nobody noticed anything different.”


* Individual patient results may vary

Schedule an appointment to find out if LATERA could be right for you.


The information provided is not intended to be used for medical diagnosis or treatment or as a substitute for professional medical advice. Please consult your physician or qualified health provider regarding your condition and appropriate medical treatment. Individual symptoms, situations and circumstances may vary.

To find out more about nasal obstruction, see the well-presented overviews by the experts at the American Academy of Otolaryngology-Head and Neck Surgery and the American Rhinologic Society.

REFERENCES

  1. Value calculated based on 2014 US population estimate from US Census and World Bank data in conjunction with incidence numbers cited in Stewart et al. Epidemiology and burden of nasal congestion. Intl J Gen Med 2010; 2010:3 37-45.
  2. Rhee et al. Nasal Valve Surgery Improves Disease-Specific Quality of Life. Laryngoscope 115: March 2005.
  3. Wever, The Nasal Airway: A Critical Review; Facial Plast Surg 2016;32:17– 21.
  4. Camacho et al, The Effect of Nasal Surgery on Continuous Positive Airway Pressure Device Use and Therapeutic Treatment Pressures: A Systematic Review and Meta-Analysis; SLEEP, Vol. 38, No. 2, 2015.
  5. Lin et al, Nasal Aerodynamics. May 14, 2015.
  6. Data on file (Spirox Report CR001) from a 30-patient Spirox clinical study conducted in Germany, in patients with confirmed nasal valve collapse as a primary factor for their nasal airway obstruction. Patients were 60% female, aged 24-77, 93% Caucasian. Study follow-up is ongoing. https://clinicaltrials.gov/ct2/show/NCT02188589.
  7. Nasal Obstruction Symptom Evaluation (NOSE) survey is a quality of life survey supported by the AAO Consensus Statement. Otolaryngology–Head and Neck Surgery: 162 STEWART et al February 2004.
  8. Market research is ongoing. Data on file (TR-21076 Spirox NVC Experience).
    Individual patient results may vary and may include other procedures. Use of the LATERA device in conjunction with other procedures (such as septoplasty and/or turbinate reduction) has not been clinically evaluated. Patient satisfaction results may be attributed to LATERA with other procedures.